Get started

X-volume

JSE:AGL Anglo American Approaching OversoldAnglo American has been trading in a well-defined advancing channel (See the previous post following this advance below). Every time it has reached the oversold line there has been a spring type action and institutional buying indicated by volume increases. The difference with the previous occasions this occurred is that the volatility is greater and has occurred a shorter perioded of time after the previous event. So watch for a reaction from the oversold line on a lower timeframe but apply good risk management due to the volatility.
JSE:AGLLong
by SteynTrade
FOMX - Bulls Arrive As Big Investment HappensFoamix Pharmaceuticals Ltd. is a clinical-stage pharmaceutical company. The Company is engaged in the development and commercialization of foam-based formulations, using its technology, which includes its foam platforms. It is focused on developing and commercializing its minocycline foam for the treatment of acne, rosacea and other skin conditions. Its product candidates include FMX101, FMX102, FMX103 and FDX104. Its lead product candidate, FMX101, is a topical foam formulation of the antibiotic minocycline for the treatment of moderate-to-severe acne. FMX102 is a formulation of its minocycline foam being developed for the treatment of impetigo. FMX103 is a topical foam formulation of minocycline for the treatment of moderate-to-severe Papulopustular rosacea. FDX104 is a topical foam formulation of the antibiotic doxycycline for the treatment of severe acne-like rashes induced by chemotherapy. It has conducted one Phase II clinical trial for each of FMX101, FMX102, FMX103 and FDX104. Foamix Pharmaceuticals Ltd. (FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in dermatology, today announced that it has secured up to $64 million in financing from Perceptive Advisors and OrbiMed. The financing consists of term loans of up to $50 million under a Credit Agreement, with $15 million provided immediately upon satisfaction of certain closing conditions, $20 million available upon the achievement of certain regulatory milestones and $15 million available upon the achievement of certain revenue milestones. Additionally, the Company will receive $14 million in gross proceeds from Perceptive Advisors through a direct registered offering of the Company’s ordinary shares. Proceeds from the transactions are expected to be used to fund the Company’s filing of a New Drug Application (“NDA”) with the FDA for FMX103 for the treatment of papulopustular rosacea as well as, assuming FDA approval is received, the anticipated product launches of FMX101 for the treatment of moderate to severe acne and FMX103, as well as for working capital and general corporate purposes. The FDA has established October 20th, 2019 as the Prescription Drug User Fee Act (PDUFA) action date for FMX101, and Foamix is in the final stages of preparation for the NDA submission for FMX103. (Source finance.yahoo.com) SHORT INTEREST 2.11M 07/15/19 Average Recommendation: BUY Average Target Price: 15.60 P/E Current -1.26 P/E Ratio (with extraordinary items) -1.84
FLong
by DEXWireNews
1
JSE:AMS Anglo American Platinum Re-accumulation Trading RangeAnglo Plat has had a good run but has now started to form a trading range. I have been following the accumulation of Anglo Plat since 2018 (See post below). It has had a great run after breaking the accumulation trading range (TR). We have seen a buying climax (BC) signalling the start of a smaller TR during the markup phase E. This could be a re-accumulation and backup to the breakout that is forming. Will watch for the action during the TR to time going long again when this is done. It may take a little time before this happens.
ALong
by SteynTrade
JSE:IMP Impala Testing the Top of the Trading RangeAfter a great run, Impala may be exhausted (See post below as we followed it on the way up). Now it has formed a smaller TR at the top of the larger TR. The smaller TR looks like distribution and could indicate that price can start moving down again within the larger TR. Divergence on the volume RSI points to selling pressure and high volume down could indicate an upthrust (UT). Price could possibly range at the top for a little longer but possibly we are looking to a break lower.
JSE:IMPShort
by SteynTrade
LTCUSD 1D TRIANGLE BREAKOUT TRADESTriangles, Ascending Triangle, Descending Triangles and Ranges are repeatable trading chart patterns. Triangles and ranges are consolidation chart patterns that can breakout either direction. Ascending and descending chart patterns will have a directional bias depending on the previous incoming trend. Each chart pattern will have defining trendlines of the support/resistance levels creating the pattern. What ever time frame you are trading this chart pattern, wait for a candle close outside of the trendline in the direction of the breakout candle. (Our time frame preference is the Daily chart). Add volume indicator - Volume is the amount of $ that went into a particular candle or in Forex the # of trades that took place. Add ATR indicator - Volatility is the amount of price movement that occurred. Use the ATR to measure the price movement. When you see descending volume bars and descending atr line (which indicates volatility) this shows a dis-interest in traders to invest in this pair creating consolidation which creates the chart pattern. Trade Management after there is a breakout candle close. 1 - Position size (compare volume bar to volume ma line). a - Breakout candle must be 100% of average volume for a full position size. b - If 75% of average volume then ½ position size. 2 - Enter two trades. 3 - SL for both trades will be 1.5 x ATR. 4 - 1st trade TP will be 1 x ATR. 5 - No TP on 2nd trade – letting profit run and adjusting SL to follow price. 6 - When 1st TP hit – move 2nd trade SL to breakeven. 7 - Adjust the 2nd trade SL to follow price. *8 - When breakout candle is more than 1 ATR from breakout candle open. a - Enter 1st trade at candle close with ½ position size. b - Enter 2nd trade with a pending limit order that is 1 ATR of breakout candle open. c – Price should pullback to that pending limit order for 2nd trade.
OANDA:XAUUSD
by Tradingstrategyguides
4
JSE:AFH Alexander Forbes Bucking the TrendI have been following the accumulation range of Alexander Forbes (See post below). Price has consolidated at the top of the TR, which is also the yearly pivot point. It has pushed above with some high volume selling pressure but remained above the TR (See the negative divergence with the volume RSI and volume spike). In spite of the week market conditions it still looks as if this is about to start the markup and is being defined by the 50 day MA and clear upward stride.
JSE:AFHLong
by SteynTrade
5